Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Explore CN1262540C technology for non-steroidal AR and PR modulators. Enhanced stability and specificity for pharmaceutical intermediate manufacturing and scale-up.
Patent CN107653273B reveals a dual-enzyme one-pot method for high-yield benzoquinone synthesis, offering green manufacturing and cost reduction for pharmaceutical intermediates.
Patent CN109369638B details a green, high-yield synthesis of dasatinib intermediates using heteropolyacid catalysis, offering significant cost reduction in API manufacturing.
Discover the novel Canertinib synthesis via CN103242244A. A streamlined, cost-effective route for high-purity pharmaceutical intermediates suitable for industrial scale-up.
Patent CN102675197A details a high-yield, eco-friendly route for Sorafenib intermediate. Reduces solvent use and improves purity for scalable manufacturing.
Novel Pd-catalyzed route for 4-pentene sulfoximine amidines. High efficiency, room temp, scalable for pharma intermediates.
Patent CN1269819C reveals a safer synthetic route for temozolomide, eliminating hazardous reagents and improving yield for cost reduction in API manufacturing.
Advanced synthesis of Melphalan and salts via pH-controlled purification. Cost-effective manufacturing using technical grade raw materials for global supply chains.
Patent CN103073508A details efficient synthesis of kinase inhibitors. Discover cost-effective routes for high-purity pharmaceutical intermediates targeting B-cell diseases.
Novel patent CN105218463B details eco-friendly Gefitinib synthesis. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis route for progesterone pyrazinamide compounds targeting prostate cancer. Efficient convergent strategy reduces costs and improves supply chain reliability for API intermediates.
Patent CN106432195B reveals a streamlined route for (R)-2-(2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide, enhancing purity and reducing costs.
Patent CN109503689B reveals a novel Guadecitabine synthesis route eliminating toxic reagents. Discover cost reduction strategies and scalable manufacturing insights for pharmaceutical intermediates.
Patent CN100537563C reveals a streamlined acid-catalyzed condensation for N-phenyl-2-pyrimidinamine derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Discover novel chromone compounds with antitumor activity. Our advanced PPA cyclization process ensures high purity and scalable supply for pharmaceutical manufacturing.
Patent CN109369631B details a novel enzymatic route for LDHA inhibitor intermediates, offering high ee values and scalable manufacturing for reliable pharmaceutical suppliers.
Patent CN102603718A details a high-yield Cediranib synthesis. Offers cost reduction in pharmaceutical manufacturing and scalable routes for reliable API intermediate supply.
Patent CN1413203A reveals a high-yield route for phthalazinones, offering safer processing and significant cost reduction for pharmaceutical manufacturing.
Advanced synthesis of pyrrolotriazine intermediates for kinase inhibitors. Optimized routes for c-Met targeting drugs with improved scalability and purity.
Novel thalidomide-based PROTACs for fibrosis and cancer. Efficient solid-phase synthesis ensures high purity and scalable supply chain solutions.